echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > After investing in the hospital and burning more than 1 billion, the listed company reluctantly "cut the meat" and left the market

    After investing in the hospital and burning more than 1 billion, the listed company reluctantly "cut the meat" and left the market

    • Last Update: 2022-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The listed company Youngor plans to withdraw from the health indust.
    It announced that it will donate Puji Hospital and related assets to the Ningbo Municipal People's Governme.
    The estimated value of the assets to be donated is 36 billion yu.
     
    The listed company donated 36 billion yuan of hospital assets to withdraw from the health industry
     
    On May 18, the A-share listed company Youngor Group .
    , L.
    (hereinafter referred to as Youngor, 600177) announced that in order to further focus on the construction of the fashion industry and enhance the core competitiveness of the company, the company plans to withdraw from the health industry and donate to the Ningbo Municipal People's Governme.
    For Puji Hospital and related assets, the estimated value of the assets to be donated is 36 billion yuan (subject to final account.
     
    According to public information, Youngor Group was founded in 1979 and is headquartered in Ningbo City, Zhejiang Provin.
    It is a leading enterprise in the national textile and garment indust.
    It has four major industries: fashion, real estate, investment and international tra.
    It ranks 68th among the top 500 private enterprises in Chi.
    As of the end of 2021, the group has total assets of 94 billion yuan and net assets of 33 billion yu.
    Youngor was listed on the Shanghai Stock Exchange in November 199
     
    In response to this donation, Younger said that in recent years, the uncertainty of the domestic and foreign economic situation has increased, the national medical system reform has been further promoted, and the company lacks the operation team and experience in related industri.
    If it continues to invest in Puji Hospital and related assets, put it into production There may be a large degree of imbalance, which is not conducive to the company's focus on capital and energy to develop its main busine.
     
    Therefore, the company decided to further focus on the main business in terms of resources, capital, team and management, and adjust the existing industrial structu.
    As of the announcement date, the book value of Puji Hospital and related assets was 074 billion yuan, and the contract amount to be paid was 286 million yu.
    At the same time, this move will be included in non-operating expenses, reducing the company's net profit in 2022 by 02 billion yuan (subject to audit dat.

     
    It is understood that Youngor's entry into the big health industry began in 2015, when it announced that it established the Youngor Health Industry Fund with its own funds, announcing its entry into the big health indust.

    In May 2018, Youngor won the right to use a piece of state-owned construction land in Haishu District, Ningbo with more than 75 million yu.

    It plans to build a large-scale general hospital with a third-class standard, and rely on it to develop the health industry and realize the transformation and exploration of the real estate sect.

    It is the Puji Hospital that was donated this ti.

     
    In October 2018, Puji Hospital officially started constructi.

    It is reported that the total construction area of ​​the project exceeds 200,000 square meters, 1,600 beds are planned to be opened, and an investment of nearly 2 billion yu.

     
    In December 2019, it was reported that Ningbo .

    2 Medical and Youngor Real Estate Holdings .

    , L.

    formally signed a comprehensive trusteeship agreement for Ningbo Puji Hospit.

    After the hospital is put into use, it will become the "Western Hospital of Ningbo .

    2 Hospita.

    The hospital has Independent International Medical Cent.

    Surprisingly, the hospital was donated as soon as the acceptance was complet.

     
    For Youngor, who runs a cross-border medical service, it is not unheard of to announce his withdrawal from the health indust.

    Since 2019, Youngor's investment strategy proposals and related financial reports and annual reports have repeatedly conveyed signals focusing on the development of the main busine.

     
    For this donation, the announcement also revealed that Youngor will speed up the adjustment of the industrial structure, expand the territory of the fashion group through cultivation, cooperation, acquisition, e.

    , enhance the brand influence, and ensure the stable and healthy development of the compa.

    Its independent directors said that this move is conducive to further focusing on the main busine.

     
    A number of listed companies withdraw from the medical service industry
     
    Similar to Youngor, many listed companies have poured into the medical and health field, such as real estate, ceramic tiles, coal, pearl farming, medicine , e.

    , under the bonus of the state's policy of encouraging social capital to run medical services in the past few years, and thus set off a wave of hospital investme.

    Merger wa.

    However, in recent years, some listed companies are facing some difficulties, and some have issued announcements to withdraw from the medical service indust.

     
    Taking the listed company Changbao as an example, it is understood that as early as 2016, Changbao, which is engaged in energy and mechanical equipment manufacturing, began to plan for a cross-border transformation of the medical service indust.

    In 2017, Changbao spent 992 million yuan to acquire medical asse.

    , but within two years, plans to gradually withdraw from the medical service indust.

     
    In January 2021, Changbao .

    , L.

    issued an announcement saying that it will continue to promote the implementation of matters related to its planned withdrawal from the medical service industry in the early stage, and implement the focus on the main business of energy pip.

    At the same time, it will sell 100% equity of Shandong Ruigao and Sichuan Shifang Second Hospital, and 90% equity of Suqian Yanghe People's Hospital to Zhongmin Jiaye and Shanghai Jiayu Medic.

     
    Not only Changbao shares, it is understood that since 2018, a number of listed companies have announced to focus on their main business and gradually divest hospital asse.

     
      As far as real estate companies are concerned, in June 2018, LVGEM Holdings, whose main business is stock property sales and property management, issued a draft for the sale of major assets, announcing the divestiture of early-stage medical projec.

    At this time, it was only three years before LVGEM Holdings planned to raise 10 billion yuan to deploy in the field of women's and children's medical services, and planned to withdraw from the real estate business and completely transform the medical fie.

     
      Compared with energy and real estate companies, pharmaceutical companies seem to have more advantages in running medical services across borders, but it is not as easy as imagin.

     
    According to reports, as early as 2014, Renfu Pharmaceutical announced that the company would deploy about 20 hospitals  in the next 3-5 year.

    However, since 2018, the company has not only failed to cultivate in the field of medical services, but also successively sold its holdin.

    related hospital equity, and announced the gradual withdrawal from the medical service segme.

     
      Coincidentally, shortly after acquiring a number of hospitals at a premium in 2014, Jingfeng Medicine also began to "sell" hospita.

    In 2018, Jingfeng Medicine announced that it planned to sell 100% of the profitable Jinsha Hospital for 150 million yu.

    He also said that the sale of Jinsha Hospital is conducive to integrating the group's resources and focusing on the development of the main business of medici.

    The company will continue to divest non-main business assets, focus on the main business, and provide sufficient cash flow guarantee for the development of the main busine.

     
      In 2019, Xianju Pharmaceutical, which has been engaged in the production of steroid drugs, and Kangmei Pharmaceutical, a well-known pharmaceutical company, also spoke out one after another, focusing on the main busine.

    In January of the same year, Xianju Pharmaceutical issued an announcement that it planned to transfer all the shares it held in Hangzhou Hengha Stomatological Hospit.

    In August, Kangmei Pharmaceutical told the media that for non-main business, the company would no longer invest any more, and combined with the external market conditions After a comprehensive evaluation, measures such as shutdown, optimization, and sale are taken to gradually dive.

     
      Cross-border medical management faces challenges in operation management
     
      Different from other industries, the medical industry has the characteristics of large investment scale and long return period, which is destined to be not a short-term and fast indust.

     
      As far as Younger's move is concerned, according to Beijing Business Daily, medical expert Zhao Heng analyzed that the difficulty of cross-border is mainly due to the reform of medical services, especially after the reform of the medical insurance payment system, hospitals are no longer a high-profit industry, and this industry is not a high-profit indust.

    more attracti.

    According to Deng Yong, a professor of law at Beijing University of Traditional Chinese Medicine , with the advancement of the national medical system reform, Youngor, which produces clothing, does not have an operation management team and certain experienc.

     
      For some pharmaceutical companies that are struggling to run medical services across borders, Xu Yucai, former deputy director of the Shanyang County Health and Health Bureau of Shaanxi Province, once said that one of the most important problems for listed companies to run medical services across borders is that running hospitals and managing hospitals are often not the sa.

    Profession.

     
      .

    Zhang Qiang, a well-known vascular surgery expert and founder of .

    Zhang Qiang Group, also said that, unlike other industries, China's medical and health industry lacks neither capital nor hospital buildin.

    A large number of doctor teams that meet international medical service standards lack a fair and orderly private public competition mechanism, and what is lacking is an international doctor training syst.

     
      In addition, some industry experts said that due to the slow return of funds, the impact on the company's main business, differences within the company's management, unacceptable conditions after crossing the border, and policy uncertainty, these listed companies have entered the field of medical servic.

    The major setback has also made some originally optimistic "crossovers" begin to reassess the price of entering the ga.

     
      The expert believes that hospital operation requires a long period of market expansion, resource accumulation and brand buildi.

    Hospitals are not a short-term busine.

      The listed company Youngor plans to withdraw from the health indust.

    It announced that it will donate Puji Hospital and related assets to the Ningbo Municipal People's Governme.

    The estimated value of the assets to be donated is 36 billion yu.

     
      The listed company donated 36 billion yuan of hospital assets to withdraw from the health industry
     
      On May 18, the A-share listed company Youngor Group .

    , L.

    (hereinafter referred to as Youngor, 600177) announced that in order to further focus on the construction of the fashion industry and enhance the core competitiveness of the company, the company plans to withdraw from the health industry and donate to the Ningbo Municipal People's Governme.

    For Puji Hospital and related assets, the estimated value of the assets to be donated is 36 billion yuan (subject to final account.

     
      According to public information, Youngor Group was founded in 1979 and is headquartered in Ningbo City, Zhejiang Provin.

    It is a leading enterprise in the national textile and garment indust.

    It has four major industries: fashion, real estate, investment and international tra.

    It ranks 68th among the top 500 private enterprises in Chi.

    As of the end of 2021, the group has total assets of 94 billion yuan and net assets of 33 billion yu.

    Youngor was listed on the Shanghai Stock Exchange in November 199
     
      In response to this donation, Younger said that in recent years, the uncertainty of the domestic and foreign economic situation has increased, the national medical system reform has been further promoted, and the company lacks the operation team and experience in related industri.

    If it continues to invest in Puji Hospital and related assets, put it into production There may be a large degree of imbalance, which is not conducive to the company's focus on capital and energy to develop its main busine.

     
      Therefore, the company decided to further focus on the main business in terms of resources, capital, team and management, and adjust the existing industrial structu.

    As of the announcement date, the book value of Puji Hospital and related assets was 074 billion yuan, and the contract amount to be paid was 286 million yu.

    At the same time, this move will be included in non-operating expenses, reducing the company's net profit in 2022 by 02 billion yuan (subject to audit dat.

     
      It is understood that Youngor's entry into the big health industry began in 2015, when it announced that it established the Youngor Health Industry Fund with its own funds, announcing its entry into the big health indust.

    In May 2018, Youngor won the right to use a piece of state-owned construction land in Haishu District, Ningbo with more than 75 million yu.

    It plans to build a large-scale general hospital with a third-class standard, and rely on it to develop the health industry and realize the transformation and exploration of the real estate sect.

    It is the Puji Hospital that was donated this ti.

     
      In October 2018, Puji Hospital officially started constructi.

    It is reported that the total construction area of ​​the project exceeds 200,000 square meters, 1,600 beds are planned to be opened, and an investment of nearly 2 billion yu.

     
      In December 2019, it was reported that Ningbo .

    2 Medical and Youngor Real Estate Holdings .

    , L.

    formally signed a comprehensive trusteeship agreement for Ningbo Puji Hospit.

    After the hospital is put into use, it will become the "Western Hospital of Ningbo .

    2 Hospita.

    The hospital has Independent International Medical Cent.

    Surprisingly, the hospital was donated as soon as the acceptance was complet.

     
      For Youngor, who runs a cross-border medical service, it is not unheard of to announce his withdrawal from the health indust.

    Since 2019, Youngor's investment strategy proposals and related financial reports and annual reports have repeatedly conveyed signals focusing on the development of the main busine.

     
      For this donation, the announcement also revealed that Youngor will speed up the adjustment of the industrial structure, expand the territory of the fashion group through cultivation, cooperation, acquisition, e.

    , enhance the brand influence, and ensure the stable and healthy development of the compa.

    Its independent directors said that this move is conducive to further focusing on the main busine.

     
      A number of listed companies withdraw from the medical service industry
     
      Similar to Youngor, many listed companies have poured into the medical and health field, such as real estate, ceramic tiles, coal, pearl farming, medicine , e.

    , under the bonus of the state's policy of encouraging social capital to run medical services in the past few years, and thus set off a wave of hospital investme.

    Merger wa.

    However, in recent years, some listed companies are facing some difficulties, and some have issued announcements to withdraw from the medical service indust.

     
      Taking the listed company Changbao as an example, it is understood that as early as 2016, Changbao, which is engaged in energy and mechanical equipment manufacturing, began to plan for a cross-border transformation of the medical service indust.

    In 2017, Changbao spent 992 million yuan to acquire medical asse.

    , but within two years, plans to gradually withdraw from the medical service indust.

     
      In January 2021, Changbao .

    , L.

    issued an announcement saying that it will continue to promote the implementation of matters related to its planned withdrawal from the medical service industry in the early stage, and implement the focus on the main business of energy pip.

    At the same time, it will sell 100% equity of Shandong Ruigao and Sichuan Shifang Second Hospital, and 90% equity of Suqian Yanghe People's Hospital to Zhongmin Jiaye and Shanghai Jiayu Medic.

     
      Not only Changbao shares, it is understood that since 2018, a number of listed companies have announced to focus on their main business and gradually divest hospital asse.

     
      As far as real estate companies are concerned, in June 2018, LVGEM Holdings, whose main business is stock property sales and property management, issued a draft for the sale of major assets, announcing the divestiture of early-stage medical projec.

    At this time, it was only three years before LVGEM Holdings planned to raise 10 billion yuan to deploy in the field of women's and children's medical services, and planned to withdraw from the real estate business and completely transform the medical fie.

     
      Compared with energy and real estate companies, pharmaceutical companies seem to have more advantages in running medical services across borders, but it is not as easy as imagin.

     
    According to reports, as early as 2014, Renfu Pharmaceutical announced that the company would deploy about 20 hospitals  in the next 3-5 year.

    However, since 2018, the company has not only failed to cultivate in the field of medical services, but also successively sold its holdin.

    related hospital equity, and announced the gradual withdrawal from the medical service segme.

     
      Coincidentally, shortly after acquiring a number of hospitals at a premium in 2014, Jingfeng Medicine also began to "sell" hospita.

    In 2018, Jingfeng Medicine announced that it planned to sell 100% of the profitable Jinsha Hospital for 150 million yu.

    He also said that the sale of Jinsha Hospital is conducive to integrating the group's resources and focusing on the development of the main business of medici.

    The company will continue to divest non-main business assets, focus on the main business, and provide sufficient cash flow guarantee for the development of the main busine.

     
      In 2019, Xianju Pharmaceutical, which has been engaged in the production of steroid drugs, and Kangmei Pharmaceutical, a well-known pharmaceutical company, also spoke out one after another, focusing on the main busine.

    In January of the same year, Xianju Pharmaceutical issued an announcement that it planned to transfer all the shares it held in Hangzhou Hengha Stomatological Hospit.

    In August, Kangmei Pharmaceutical told the media that for non-main business, the company would no longer invest any more, and combined with the external market conditions After a comprehensive evaluation, measures such as shutdown, optimization, and sale are taken to gradually dive.

     
      Cross-border medical management faces challenges in operation management
     
      Different from other industries, the medical industry has the characteristics of large investment scale and long return period, which is destined to be not a short-term and fast indust.

     
      As far as Younger's move is concerned, according to Beijing Business Daily, medical expert Zhao Heng analyzed that the difficulty of cross-border is mainly due to the reform of medical services, especially after the reform of the medical insurance payment system, hospitals are no longer a high-profit industry, and this industry is not a high-profit indust.

    more attracti.

    According to Deng Yong, a professor of law at Beijing University of Traditional Chinese Medicine , with the advancement of the national medical system reform, Youngor, which produces clothing, does not have an operation management team and certain experienc.

     
      For some pharmaceutical companies that are struggling to run medical services across borders, Xu Yucai, former deputy director of the Shanyang County Health and Health Bureau of Shaanxi Province, once said that one of the most important problems for listed companies to run medical services across borders is that running hospitals and managing hospitals are often not the sa.

    Profession.

     
      .

    Zhang Qiang, a well-known vascular surgery expert and founder of .

    Zhang Qiang Group, also said that, unlike other industries, China's medical and health industry lacks neither capital nor hospital buildin.

    A large number of doctor teams that meet international medical service standards lack a fair and orderly private public competition mechanism, and what is lacking is an international doctor training syst.

     
      In addition, some industry experts said that due to the slow return of funds, the impact on the company's main business, differences within the company's management, unacceptable conditions after crossing the border, and policy uncertainty, these listed companies have entered the field of medical servic.

    The major setback has also made some originally optimistic "crossovers" begin to reassess the price of entering the ga.

     
      The expert believes that hospital operation requires a long period of market expansion, resource accumulation and brand buildi.

    Hospitals are not a short-term busine.

      The listed company Youngor plans to withdraw from the health indust.

    It announced that it will donate Puji Hospital and related assets to the Ningbo Municipal People's Governme.

    The estimated value of the assets to be donated is 36 billion yu.

     
      The listed company donated 36 billion yuan of hospital assets to withdraw from the health industry
      The listed company donated 36 billion yuan of hospital assets to withdraw from the health industry
     
      On May 18, the A-share listed company Youngor Group .

    , L.

    (hereinafter referred to as Youngor, 600177) announced that in order to further focus on the construction of the fashion industry and enhance the core competitiveness of the company, the company plans to withdraw from the health industry and donate to the Ningbo Municipal People's Governme.

    For Puji Hospital and related assets, the estimated value of the assets to be donated is 36 billion yuan (subject to final account.

     
      According to public information, Youngor Group was founded in 1979 and is headquartered in Ningbo City, Zhejiang Provin.

    It is a leading enterprise in the national textile and garment indust.

    It has four major industries: fashion, real estate, investment and international tra.

    It ranks 68th among the top 500 private enterprises in Chi.

    As of the end of 2021, the group has total assets of 94 billion yuan and net assets of 33 billion yu.

    Youngor was listed on the Shanghai Stock Exchange in November 199
     
      In response to this donation, Younger said that in recent years, the uncertainty of the domestic and foreign economic situation has increased, the national medical system reform has been further promoted, and the company lacks the operation team and experience in related industri.

    If it continues to invest in Puji Hospital and related assets, put it into production There may be a large degree of imbalance, which is not conducive to the company's focus on capital and energy to develop its main busine.

     
      Therefore, the company decided to further focus on the main business in terms of resources, capital, team and management, and adjust the existing industrial structu.

    As of the announcement date, the book value of Puji Hospital and related assets was 074 billion yuan, and the contract amount to be paid was 286 million yu.

    At the same time, this move will be included in non-operating expenses, reducing the company's net profit in 2022 by 02 billion yuan (subject to audit dat.

     
      It is understood that Youngor's entry into the big health industry began in 2015, when it announced that it established the Youngor Health Industry Fund with its own funds, announcing its entry into the big health indust.

    In May 2018, Youngor won the right to use a piece of state-owned construction land in Haishu District, Ningbo with more than 75 million yu.

    It plans to build a large-scale general hospital with a third-class standard, and rely on it to develop the health industry and realize the transformation and exploration of the real estate sect.

    It is the Puji Hospital that was donated this ti.

     
      In October 2018, Puji Hospital officially started constructi.

    It is reported that the total construction area of ​​the project exceeds 200,000 square meters, 1,600 beds are planned to be opened, and an investment of nearly 2 billion yu.

     
      In December 2019, it was reported that Ningbo .

    2 Medical and Youngor Real Estate Holdings .

    , L.

    formally signed a comprehensive trusteeship agreement for Ningbo Puji Hospit.

    After the hospital is put into use, it will become the "Western Hospital of Ningbo .

    2 Hospita.

    The hospital has Independent International Medical Cent.

    Surprisingly, the hospital was donated as soon as the acceptance was complet.

     
      For Youngor, who runs a cross-border medical service, it is not unheard of to announce his withdrawal from the health indust.

    Since 2019, Youngor's investment strategy proposals and related financial reports and annual reports have repeatedly conveyed signals focusing on the development of the main busine.

     
      For this donation, the announcement also revealed that Youngor will speed up the adjustment of the industrial structure, expand the territory of the fashion group through cultivation, cooperation, acquisition, e.

    , enhance the brand influence, and ensure the stable and healthy development of the compa.

    Its independent directors said that this move is conducive to further focusing on the main busine.

     
      A number of listed companies withdraw from the medical service industry
      A number of listed companies withdraw from the medical service industry
     
      Similar to Youngor, many listed companies have poured into the medical and health field, such as real estate, ceramic tiles, coal, pearl farming, medicine , e.

    , under the bonus of the state's policy of encouraging social capital to run medical services in the past few years, and thus set off a wave of hospital investme.

    Merger wa.

    However, in recent years, some listed companies are facing some difficulties, and some have issued announcements to withdraw from the medical service indust.

    medicine medicine medicine
     
      Taking the listed company Changbao as an example, it is understood that as early as 2016, Changbao, which is engaged in energy and mechanical equipment manufacturing, began to plan for a cross-border transformation of the medical service indust.

    In 2017, Changbao spent 992 million yuan to acquire medical asse.

    , but within two years, plans to gradually withdraw from the medical service indust.

     
      In January 2021, Changbao .

    , L.

    issued an announcement saying that it will continue to promote the implementation of matters related to its planned withdrawal from the medical service industry in the early stage, and implement the focus on the main business of energy pip.

    At the same time, it will sell 100% equity of Shandong Ruigao and Sichuan Shifang Second Hospital, and 90% equity of Suqian Yanghe People's Hospital to Zhongmin Jiaye and Shanghai Jiayu Medic.

     
      Not only Changbao shares, it is understood that since 2018, a number of listed companies have announced to focus on their main business and gradually divest hospital asse.

     
      As far as real estate companies are concerned, in June 2018, LVGEM Holdings, whose main business is stock property sales and property management, issued a draft for the sale of major assets, announcing the divestiture of early-stage medical projec.

    At this time, it was only three years before LVGEM Holdings planned to raise 10 billion yuan to deploy in the field of women's and children's medical services, and planned to withdraw from the real estate business and completely transform the medical fie.

    enterprise enterprise enterprise
     
      Compared with energy and real estate companies, pharmaceutical companies seem to have more advantages in running medical services across borders, but it is not as easy as imagin.

     
    According to reports, as early as 2014, Renfu Pharmaceutical announced that the company would deploy about 20 hospitals  in the next 3-5 year.

    However, since 2018, the company has not only failed to cultivate in the field of medical services, but also successively sold its holdin.

    related hospital equity, and announced the gradual withdrawal from the medical service segme.

    hospital hospital hospital
     
      Coincidentally, shortly after acquiring a number of hospitals at a premium in 2014, Jingfeng Medicine also began to "sell" hospita.

    In 2018, Jingfeng Medicine announced that it planned to sell 100% of the profitable Jinsha Hospital for 150 million yu.

    He also said that the sale of Jinsha Hospital is conducive to integrating the group's resources and focusing on the development of the main business of medici.

    The company will continue to divest non-main business assets, focus on the main business, and provide sufficient cash flow guarantee for the development of the main busine.

     
      In 2019, Xianju Pharmaceutical, which has been engaged in the production of steroid drugs, and Kangmei Pharmaceutical, a well-known pharmaceutical company, also spoke out one after another, focusing on the main busine.

    In January of the same year, Xianju Pharmaceutical issued an announcement that it planned to transfer all the shares it held in Hangzhou Hengha Stomatological Hospit.

    In August, Kangmei Pharmaceutical told the media that for non-main business, the company would no longer invest any more, and combined with the external market conditions After a comprehensive evaluation, measures such as shutdown, optimization, and sale are taken to gradually dive.

     
      Cross-border medical management faces challenges in operation management
      Cross-border medical management faces challenges in operation management
     
      Different from other industries, the medical industry has the characteristics of large investment scale and long return period, which is destined to be not a short-term and fast indust.

     
      As far as Younger's move is concerned, according to Beijing Business Daily, medical expert Zhao Heng analyzed that the difficulty of cross-border is mainly due to the reform of medical services, especially after the reform of the medical insurance payment system, hospitals are no longer a high-profit industry, and this industry is not a high-profit indust.

    more attracti.

    According to Deng Yong, a professor of law at Beijing University of Traditional Chinese Medicine , with the advancement of the national medical system reform, Youngor, which produces clothing, does not have an operation management team and certain experienc.

    Traditional Chinese Medicine Traditional Chinese Medicine
     
      For some pharmaceutical companies that are struggling to run medical services across borders, Xu Yucai, former deputy director of the Shanyang County Health and Health Bureau of Shaanxi Province, once said that one of the most important problems for listed companies to run medical services across borders is that running hospitals and managing hospitals are often not the sa.

    Profession.

     
      .

    Zhang Qiang, a well-known vascular surgery expert and founder of .

    Zhang Qiang Group, also said that, unlike other industries, China's medical and health industry lacks neither capital nor hospital buildin.

    A large number of doctor teams that meet international medical service standards lack a fair and orderly private public competition mechanism, and what is lacking is an international doctor training syst.

    healthy healthy healthy
     
      In addition, some industry experts said that due to the slow return of funds, the impact on the company's main business, differences within the company's management, unacceptable conditions after crossing the border, and policy uncertainty, these listed companies have entered the field of medical servic.

    The major setback has also made some originally optimistic "crossovers" begin to reassess the price of entering the ga.

     
      The expert believes that hospital operation requires a long period of market expansion, resource accumulation and brand buildi.

    Hospitals are not a short-term busine.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.